Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction (original) (raw)

• Greenwald, R.J., Freeman, G.J. & Sharpe, A.H. The B7 family revisited. Annu. Rev. Immunol. 23, 515–548 (2005).
  PubMed Google Scholar
• Chen, L. Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4, 336–347 (2004).
  Article CAS PubMed Google Scholar
• Watts, T.H. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23, 23–68 (2005).
  Article CAS PubMed Google Scholar
• Barber, D.L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682–687 (2006).
  Article CAS PubMed Google Scholar
• Day, C.L. et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350–354 (2006).
  Article CAS PubMed Google Scholar
• Trautmann, L. et al. Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction. Nat Med (2006).
• Petrovas, C. et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J. Exp. Med. 203, 2281–2292 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Leach, D.R., Krummel, M.F. & Allison, J.P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734–1736 (1996).
  Article CAS PubMed Google Scholar
• Hodi, F.S. et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc. Natl. Acad. Sci. USA 100, 4712–4717 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Phan, G.Q. et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA 100, 8372–8377 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Egen, J.G., Kuhns, M.S. & Allison, J.P. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 3, 611–618 (2002).
  Article CAS PubMed Google Scholar
• von Boehmer, H. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6, 338–344 (2005).
  Article CAS PubMed Google Scholar
• Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985–988 (1995).
  Article CAS PubMed Google Scholar
• Anderson, K.M., Czinn, S.J., Redline, R.W. & Blanchard, T.G. Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection. J. Immunol. 176, 5306–5313 (2006).
  Article CAS PubMed Google Scholar
• Zubairi, S., Sanos, S.L., Hill, S. & Kaye, P.M. Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani. Eur. J. Immunol. 34, 1433–1440 (2004).
  Article CAS PubMed Google Scholar
• Gomes, N.A., Gattass, C.R., Barreto-De-Souza, V., Wilson, M.E. & DosReis, G.A. TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar. J. Immunol. 164, 2001–2008 (2000).
  Article CAS PubMed Google Scholar
• Graefe, S.E., Jacobs, T., Wachter, U., Broker, B.M. & Fleischer, B. CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection. Parasite Immunol. 26, 19–28 (2004).
  Article CAS PubMed Google Scholar
• Jacobs, T., Graefe, S.E., Niknafs, S., Gaworski, I. & Fleischer, B. Murine malaria is exacerbated by CTLA-4 blockade. J. Immunol. 169, 2323–2329 (2002).
  Article CAS PubMed Google Scholar
• Bachmann, M.F. et al. Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. J. Immunol. 160, 95–100 (1998).
  CAS PubMed Google Scholar
• Homann, D. et al. Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity. J. Virol. 80, 270–280 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Day, C.L. & Walker, B.D. Progress in defining CD4 helper cell responses in chronic viral infections. J. Exp. Med. 198, 1773–1777 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Hryniewicz, A. et al. CTLA-4 blockade decreases TGF-β, indoleamine 2,3-dioxygenase, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood 108, 3834–3842 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Zaunders, J.J. et al. Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. J. Virol. 80, 10162–10172 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Leng, Q., Bentwich, Z., Magen, E., Kalinkovich, A. & Borkow, G. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention. AIDS 16, 519–529 (2002).
  Article CAS PubMed Google Scholar
• Thio, C.L. et al. Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. J. Virol. 78, 11258–11262 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Addo, M.M. et al. Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection. PLoS ONE 2, e321 (2007).
  Article PubMed PubMed Central Google Scholar
• Teft, W.A., Kirchhof, M.G. & Madrenas, J. A molecular perspective of CTLA-4 function. Annu. Rev. Immunol. 24, 65–97 (2006).
  Article CAS PubMed Google Scholar
• Krummel, M.F. & Allison, J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533–2540 (1996).
  Article CAS PubMed Google Scholar
• Kaufmann, D.E. et al. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of Gag and Nef and the presence of broadly recognized peptides. J. Virol. 78, 4463–4477 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Palmer, S. et al. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 41, 4531–4536 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Kinter, A.L. et al. CD25+CD4+ regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4+ and CD8+ HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200, 331–343 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Nilsson, J. et al. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108, 3808–3817 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kinter, A. et al. Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc. Natl. Acad. Sci. USA 104, 3390–3395 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330–336 (2003).
  Article CAS PubMed Google Scholar
• Liu, W. et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203, 1701–1711 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Seddiki, N. et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203, 1693–1700 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Harari, A., Petitpierre, S., Vallelian, F. & Pantaleo, G. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103, 966–972 (2004).
  Article CAS PubMed Google Scholar
• Iyasere, C.A. et al. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cell is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J. Virol. 77, 10900–10909 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Palmer, B.E., Boritz, E. & Wilson, C.C. Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function. J. Immunol. 172, 3337–3347 (2004).
  Article CAS PubMed Google Scholar
• Tilton, J.C. et al. Changes in paracrine IL-2 requirement, CCR7 expression, frequency, and cytokine secretion, of HIV-specific CD4+ T cells are a consequence of antigen load. J. Virol. 81, 2713–2725 (2007).
  Article CAS PubMed Google Scholar
• Sutmuller, R.P. et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. 194, 823–832 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Parry, R.V. et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 25, 9543–9553 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Betts, M.R. et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75, 11983–11991 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Dorfman, D.M., Brown, J.A., Shahsafaei, A. & Freeman, G.J. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am. J. Surg. Pathol. 30, 802–810 (2006).
  Article PubMed PubMed Central Google Scholar
• Boritz, E., Palmer, B.E. & Wilson, C.C. Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels. J. Virol. 78, 12638–12646 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Brown, J.A. et al. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170, 1257–1266 (2003).
  Article CAS PubMed Google Scholar